Clinical use of adiponectin as a marker of metabolic dysregulation

摘要: Adiponectin concentrations exhibit strong cross-sectional relationships with obesity, inflammation, and diabetes. have been extensively evaluated as epidemiologic markers of diabetes cardiovascular disease risk. In the present review we will provide an overview these backdrop for evaluation clinical applications adiponectin measurements. These include using indicator need preventive or therapeutic intervention, a predictor response to therapy, marker effectiveness. efforts are laying groundwork transition measurements from laboratory clinic.